Tag - Myomo

Myomo® to Present at Noble Capital Markets’ 15th Annual Investor Conference

Myomo, Inc., a wearable medical robotics company, today announced that it will be presenting at NobleCon15 – Noble Capital Markets’ Fifteenth Annual Investor Conference at the W Hotel, Fort Lauderdale, Florida on Monday, January 28th at 10:30 AM EST – Studio 3. Chairman and Chief Executive Officer Paul R. Gudonis and Chief Financial Officer Ralph A. Goldwasser will be presenting, as well as meeting with investors. Read more >>

Myomo® Receives Medicare Codes

Myomo, Inc., a wearable medical robotics company, announces that the Centers for Medicare & Medicaid Services has published two new codes pursuant to the Company’s application for Healthcare Common Procedure Coding System “L” codes. Read more >>

Powered brace proves restoring arm functionality is no longer out of reach

Wearable technologies such as exosuits can enhance people’s baseline abilities by giving them the ability to walk further or lift more than they would ordinarily be able to. In some cases, this means helping non-disabled people to carry out tasks more efficiently. Where it’s more profound, however, is in helping people with disabilities to perform actions that might otherwise be impossible.
This is where a powered brace called the MyoPro myoelectric arm orthosis excels. Manufactured by the wearable medical robotics […]

Myomo to Present at The MicroCap Conference

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will be presenting at The MicroCap Conference on Monday, October 1st at 11:00 AM EDT, Track 1, Essex House in New York City. Read more >>

Myomo Appoints Micah Mitchell as Chief Commercial Officer

Myomo, Inc., a wearable medical robotics company, announced today that Micah Mitchell is joining the company as chief commercial officer (CCO), a newly created executive role. The addition of a CCO reflects Myomo’s transition from a controlled introduction of its proprietary MyoPro product line to expansion of its sales, marketing, and distribution activities to address the large unmet need of expanded mobility for individuals with arm and hand paralysis. Read more >>

TBI Study Using the Myomo MyoPro Suggests Promising Results

Promising preliminary case results from a clinical trial evaluating the effects of the MyoPro myoelectric arm orthosis (powered brace) from Myomo on traumatic brain injury (TBI) patients at the Cleveland VA Medical Center were presented recently at the American Academy of Orthotists and Prosthetists Annual Scientific Meeting. Read more >>

Myomo® Application for Medicare Codes Receives Favorable Preliminary Decision

Myomo, Inc., a wearable medical robotics company, announces that the Centers for Medicare & Medicaid Services (“CMS”) has published a favorable preliminary decision regarding the Company’s application for Healthcare Common Procedure Coding System (HCPCS) “L” codes. Myomo had filed its application in December 2017 to have CMS establish two new Level II HCPCS codes to describe “microprocessor-controlled, custom fabricated upper extremity braces. Read more >>